Thomson Medical (SGX:A50) expects to swing to a loss after tax for the fiscal first half ended Dec. 31, 2024, after booking a SG$4.9 million profit in the year-ago period, according to a filing with the Singapore Exchange on Friday.
The company attributed the anticipated loss to the "poorer performance" of the Malaysian market, resulting from the termination of certain insurance contracts and increased expenses.
The company is expected to release its financial results on or before Feb. 14.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。